The US Food and Drug Administration (FDA) on Friday approved Minnesota-based St. Jude Medical’s Amplatzer PFO Occluder, which is intended to reduce the risk of a stroke for some patients who ...

The device, used to lower the risk of stroke, is intended for patients who already had one stroke caused by a blood clot passing through a hole in the heart and into the brain. The device prevents a ...

A group of physicians assembled Tuesday on behalf of the FDA to rule that St. Jude Medical’s new heart device appears safe and effective in stroke prevention, according to the Minneapolis Star Tribune ...

The US Food and Drug Administration (FDA) has granted a waiver to allow the chairman of its Circulatory System Devices advisory panel to keep his position later this month despite a conflict of ...

Abbott has launched its Amplatzer Tailsman PFO Occlosion System in Europe. The device is designed to treat people with a patent foramen ovale (PFO) who have had a stroke and are at risk of having ...

Abbott Laboratories ABT recently launched its Amplatzer Talisman PFO Occlusion System in Europe. The Talisman device aims to treat patent foramen ovale (PFO) patients who have had a stroke and are at ...